Search Results - "Leyk, M."

A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies by Curigliano, G., Jimenez, M.M., Shimizu, T., Keam, B., Meric-Bernstam, F., Rutten, A., Glaspy, J., Schuler, P.J., Parikh, N.S., Ising, M., Hassounah, N., Wu, J., Leyk, M., Chen, X., Burks, H., Chaudhury, A., Otero, J., Cabanas, E.Garralda

“…LHC165 is a Toll-like receptor (TLR)-7 agonist that generates an effective tumor antigen-specific T-cell adaptive immune response as well as durable antitumor…”
Get full text

Quality control of DL,CO instruments in global clinical trials by Jensen, R, Leyk, M, Crapo, R, Muchmore, D, Berclaz, P. Y

“…High inter- and intra-laboratory variability exists for the single-breath diffusing capacity of the lung for carbon monoxide (D(L,CO)) test. To detect small…”
Get full text

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis by Kappos, Ludwig, Radue, Ernst-Wilhelm, O'Connor, Paul, Polman, Chris, Hohlfeld, Reinhard, Calabresi, Peter, Selmaj, Krzysztof, Agoropoulou, Catherine, Leyk, Malgorzata, Zhang-Auberson, Lixin, Burtin, Pascale

“…In this 24-month, randomized trial involving patients with relapsing–remitting multiple sclerosis, oral fingolimod reduced the rates of relapse and disability…”
Get full text

Explicit representation theory of the quantum weyl algebra at roots of 1 by Boyette, J., Leyk, M., Talley, J., Plunkett, T., Sipe, K.

Get full text

Quality control of D L,CO instruments in global clinical trials by Jensen, R., Leyk, M., Crapo, R., Muchmore, D., Berclaz, P. Y.

“…High inter- and intra-laboratory variability exists for the single-breath diffusing capacity of the lung for carbon monoxide ( D L,CO ) test. To detect small…”
Get full text

Estrogen regulation of the cytochrome P450 3A subfamily in humans by Williams, Eric T, Leyk, Małgorzata, Wrighton, Steven A, Davies, Peter J A, Loose, David S, Shipley, Gregory L, Strobel, Henry W

“…This study examines the possible role of estrogen in regulating the expression of the human CYP3A subfamily: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. To accomplish…”
Get more information